Michael G Oefelein Clinical Trials
Clinical research site in Bakersfield, California
As of September 2026, 5 paid clinical trials are recruiting at Michael G Oefelein Clinical Trials in Bakersfield, California. Active studies at this site cover conditions such as Benign Prostatic Hyperplasia, Bladder (Urothelial, Transitional Cell) Cancer and NMIBC. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Michael G Oefelein Clinical Trials (5)
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms
A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)
Get new-trial alerts for Michael G Oefelein Clinical Trials
We'll email you whenever a new clinical trial starts recruiting at this research site in Bakersfield, CA. Unsubscribe anytime.
More research sites in Bakersfield
- AIS Cancer Center at San Joaquin Community Hospital (9 trials)
- California Retina Consultants (5 trials)
- GSK Investigational Site (3 trials)
- CBCC Global Research (2 trials)
- California Retina Consultants (Bakersfield) (2 trials)
- Comprehensive Blood and Cancer Center (2 trials)
- Michael G Oefelein, MD Clinical Trials (2 trials)
- Michael Oefelein Clinical Trials (2 trials)
- Kern Research, Inc. (2 trials)
- ADARx Clinical Site (1 trial)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.
Explore more
Paid clinical trials in Bakersfield, CA · California clinical trials